Interesting findings regarding the metabolic health of individuals with GS were also obtained by Mölzer et al. [32], who demonstrated that people with GS had lower BMI, lower blood glucose, insulin, C-peptide, and triacylglycerol levels compared to healthy controls and were less prone to metabolic diseases or premature death. Here, INS is linked to metabolic disease.